Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration-Reference-Cited by-同舟云学术

Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration

Published:2020-01 Issue:1 Volume:16 Page:49-59
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's Dement.

Author:

Olney Nicholas T.¹,Ong Elise¹,Goh Sheng-Yang M.¹,Bajorek Lynn¹,Dever Reilly¹,Staffaroni Adam M.¹,Cobigo Yann¹,Bock Meredith¹,Chiang Kevin¹,Ljubenkov Peter¹,Kornak John¹,Heuer Hilary W.¹,Wang Ping¹,Rascovsky Katya²,Wolf Amelia¹,Appleby Brian³,Bove Jessica²,Bordelon Yvette⁴,Brannelly Patrick⁵,Brushaber Danielle⁶,Caso Christine⁷,Coppola Giovanni⁴,Dickerson Bradford C.⁸,Dickinson Susan⁹,Domoto-Reilly Kimiko⁷,Faber Kelly¹⁰,Ferrall Jessica¹¹,Fields Julie¹²,Fishman Ann¹³,Fong Jamie¹,Foroud Tatiana¹⁰,Forsberg Leah K.¹²,Gearhart Debra J.¹²,Ghazanfari Behnaz¹⁴,Ghoshal Nupur¹⁵¹⁶,Goldman Jill¹⁷¹⁸,Graff-Radford Jonathan¹²,Graff-Radford Neill R.¹⁹,Grant Ian²⁰,Grossman Murray²,Haley Dana¹⁹,Hsiung Gingyuek²¹,Huey Edward D.¹⁷¹⁸,Irwin David J.²,Jones David T.¹²,Kantarci Kejal¹²,Karydas Anna M.¹,Kaufer Daniel¹¹,Kerwin Diana²²²³,Knopman David S.¹²,Kramer Joel H.¹,Kraft Ruth¹²,Kremers Walter⁶,Kukull Walter²⁴,Lapid Maria I.¹²,Litvan Irene²⁵,Mackenzie Ian R.²⁶,Maldonado Miranda⁴,Manoochehri Masood¹⁷¹⁸,McGinnis Scott M.⁸,McKinley Emily C.²⁷,Mendez Mario F.⁴,Miller Bruce L.¹,Onyike Chiadi¹³,Pantelyat Alex²⁸,Pearlman Rodney²⁹,Petrucelli Len¹⁹,Potter Madeleine¹⁰,Rademakers Rosa¹⁹,Ramos Eliana M.⁴,Rankin Katherine P.¹,Roberson Erik D.²⁷,Rogalski Emily²⁰,Sengdy Pheth²¹,Shaw Leslie M.²,Syrjanen Jeremy⁶,Tartaglia M. Carmela¹⁴³⁰,Tatton Nadine⁹,Taylor Joanne¹,Toga Arthur³¹,Trojanowski John Q.²,Weintraub Sandra²⁰,Wong Bonnie⁸,Wszolek Zbigniew¹⁹,Boxer Adam L.¹,Boeve Brad F.¹²,Rosen Howard J.¹,

Affiliation:

1. Department of Neurology; Memory and Aging Center, University of California, San Francisco; San Francisco CA USA

2. Department of Neurology; Perelman School of Medicine, University of Pennsylvania; Philadelphia PA USA

3. Department of Neurology; Case Western Reserve University; Cleveland OH USA

4. Department of Neurology; University of California, Los Angeles; Los Angeles CA USA

5. Tau Consortium; Rainwater Charitable Foundation; Fort Worth TX USA

6. Department of Health Sciences Research; Mayo Clinic; Rochester MN USA

7. Department of Neurology; University of Washington; Seattle WA USA

8. Department of Neurology; Frontotemporal Disorders Unit; Massachusetts General Hospital; Harvard Medical School; Boston MA USA

9. Association for Frontotemporal Degeneration; Radnor PA USA

10. National Centralized Repository for Alzheimer's Disease and Related Disorders (NCRAD); Indiana University; Indianapolis IN USA

11. Department of Neurology; University of North Carolina; Chapel Hill NC USA

12. Department of Neurology; Mayo Clinic; Rochester MN USA

13. Department of Psychiatry and Behavioral Sciences; School of Medicine; Johns Hopkins University; Baltimore MD USA

14. Division of Neurology; Department of Medicine; University of Toronto; Toronto Ontario Canada

15. Department of Psychiatry; Washington University; St. Louis MO USA

16. Department of Neurology; Washington University; St. Louis MO USA

17. Taub Institute for Research on Alzheimer’s Disease and the Aging Brain; Columbia University; New York NY USA

18. Department of Neurology; Columbia University; New York NY USA

19. Department of Neurology; Mayo Clinic; Jacksonville FL USA

20. Department of Neurology; Feinberg School of Medicine; Northwestern University; Chicago IL USA

21. Division of Neurology; Department of Medicine; University of British Columbia; Vancouver British Columbia Canada

22. Department of Neurology and Neurotherapeutics; Center for Alzheimer’s and Neurodegenerative Diseases; The University of Texas; Southwestern Medical Center at Dallas; Dallas TX USA

23. Department of Internal Medicine; The University of Texas; Southwestern Medical Center at Dallas; Dallas TX USA

24. National Alzheimer Coordinating Center (NACC); University of Washington; Seattle WA USA

25. Department of Neurosciences, Parkinson and Other Movement Disorders Center; University of California, San Diego; San Diego CA USA

26. Department of Pathology and Laboratory Medicine; University of British Columbia; Vancouver BC Canada

27. Department of Neurology; Alzheimer’s Disease Center; University of Alabama at Birmingham; Birmingham AL USA

28. Department of Neurology; School of Medicine; Johns Hopkins University; Baltimore MD USA

29. The Bluefield Project; San Francisco CA USA

30. Tanz Centre for Research in Neurodegenerative Diseases; University of Toronto; Toronto ON Canada

31. Laboratory of Neuroimaging (LONI); University of Southern California; Los Angeles CA USA

Funder

Centers for Disease Control

Biogen

Alector

NIH

Mayo Clinic

Little Family Foundation

AbbVie

Bristol-Myers Squibb

C2N Diagnostics

Tau Research Consortium

Association for Frontotemporal Degeneration

Corticobasal Degeneration Solutions

Alzheimer's Drug Discovery Foundation

Alzheimer's Association

Avid

BMS

C2N

Cortice

Eli Lilly

Forum

Genentech

Janssen

Novartis

Pfizer

Roche

TauRx

Avid Radiopharmaceuticals

Janssen Pharmaceuticals

Bristol Myers Squibb

Janssen Immunotherapy

Wyeth

SNIFF

Tau Consortium

Association for Frontotemporal Dementia

HDSA

New York State Department of Health

Lilly

Piramal

AstraZeneca

Canadian Institutes of Health Research

Alzheimer Society of British Columbia

BrightFocus Foundation

Penn Institute on Aging

Minnesota Partnership for Biotechnology and Medical Genomics

Abbvie

Janssen Research & Development

Navidea Biopharmaceuticals

HRSA

Bryan Family Foundation

Eisai

UCSF

University of Southern California

DOD

Parkinson Study Group

Parkinson Foundation

Michael J Fox Foundation

AVID Pharmaceuticals

Allon Therapeutics Inc

Eisai Inc.

Eli Lilly and Co.

Medivation

Merck

TauRx Therapeutics

NIA

CIHR

Jane Tanger Black

Biogen, Inc

Larry L. Hillblom foundation

Mayo Clinic Center for Regenerative Medicine

National Institutes of Health

Larry L. Hillblom Foundation

National Institute on Aging

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1016/j.jalz.2019.08.196/fullpdf

Reference25 articles.

1. Frontotemporal dementia;Deleon;Handb Clin Neurol,2018

2. Therapy and clinical trials in frontotemporal dementia: past, present, and future;Tsai;J Neurochem,2016

3. Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management;Rabinovici;CNS Drugs,2010

4. Advances in understanding the molecular basis of frontotemporal dementia;Rademakers;Nat Rev Neurol,2012

5. Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS);Weintraub;Alzheimer Dis Assoc Disord,2018

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Examining Associations Between Smartphone Use and Clinical Severity in Frontotemporal Dementia: Proof-of-Concept Study;JMIR Aging;2024-06-26

2. Analysis of convolutional neural networks for fronto-temporal dementia biomarker discovery;International Journal of Computer Assisted Radiology and Surgery;2024-06-14

3. The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biology;Nature Reviews Neurology;2024-05-20

4. Reliability and Validity of Smartphone Cognitive Testing for Frontotemporal Lobar Degeneration;JAMA Network Open;2024-04-01

5. Examining Associations Between Smartphone Use and Clinical Severity in Frontotemporal Dementia: Proof-of-Concept Study (Preprint);2023-09-16